SB-221284
SB 221284 is a selective 5-HT2C/2B receptor antagonist with pKi values are 6.4, 7.9 and 8.6 for 5-HT2A, 5-HT2B and 5-HT2C receptors, respectively. SB 221284 can be used for the research of neurological disease.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 196965-14-7
- Formule: C16H14F3N3OS
- Masse moléculaire:353.36
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Voir tous les produits spécifiques à Isoform 5-HT Receptor
More
Activité biologique
|
5-HT2A Receptor |
5-HT2B Receptor |
5-HT2C Receptor |
5-HT2A Receptor 6.4 (pKi) |
5-HT2B Receptor 7.9 (pKi) |
5-HT2C Receptor 8.6 (pKi) |
SB 221284 (1 mg/kg, i.p.) significantly enhances the magnitude and duration of the increase induced by phencyclidine[1]
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male Sprague Dawley rats (250–360 g)[1]
-
Dosage:0.1~1 mg/kg
-
Administration:I.p.
-
Result:Pre-treatment doses showed to block mCPP induced hypolocomotion, significantly enhanced the hyperactivity induced by phencyclidine or MK-801.
-
Animal Model:Male Sprague Dawley rats (250–360 g)[1]
-
Dosage:1 mg/kg
-
Administration:I.p.
-
Result:Significantly enhanced the magnitude and duration of the increase induced by phencyclidine.
Chemical Information
-
CAS No. 196965-14-7
-
Masse moléculaire 353.36
-
Formule C16H14F3N3OS
-
SMILES
O=C(N1CCC2=C1C=C(C(F)(F)F)C(SC)=C2)NC3=CC=CN=C3
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Hutson PH, et al. Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: neurochemical and behavioural studies. Neuropharmacology. 2000;39(12):2318-2328. [Content Brief]
[2]. Bromidge SM, et al. Novel and selective 5-HT2C/2B receptor antagonists as potential anxiolytic agents: synthesis, quantitative structure-activity relationships, and molecular modeling of substituted 1-(3-pyridylcarbamoyl)indolines. J Med Chem. 1998;41(10):1598-1612. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)